The RTA, Talia's first product, was originally designed to diagnose back-of-the-eye diseases. The product was sold to general ophthalmologists, retina and glaucoma specialists and doctors of optometry in private eye clinics and hospitals. The RTA 5 is the latest version of the original product and is continuing to serve this market with extensive upgrades and improvements.

Technological breakthroughs and significant R&D efforts, have enabled us to offer the RTA 3 - a product based on the RTA platform to the primary care setting (Optometry offices and Optical stores) for vision wellness screening.

A few years ago Talia developed the VSL Analyzer - a diagnostic application for the assessment of stroke risk , opening the door for new non-ophthalmic diagnostic solutions through retinal vasculature analysis.